Nashville, TN, United States of America

Nipun B Merchant

This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nipun B Merchant. Retrieved from https://idiyas.com/inventor/nipun-b-merchant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nipun B Merchant: Innovator in Cancer Diagnosis and Treatment

Introduction

Nipun B Merchant is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of cancer diagnosis and treatment. His innovative work focuses on the development of new tumor suppressors, which can potentially change the landscape of cancer therapies.

Latest Patents

Nipun B Merchant holds 1 patent for his invention titled "Four-jointed box (FJX1)." This patent relates to a new tumor suppressor designated FJX1. The invention describes the diagnostic, prognostic, and therapeutic uses of the FJX1 protein and the FJX1 gene, either alone or in combination with traditional cancer therapies. This groundbreaking work aims to enhance the effectiveness of cancer treatment options available today.

Career Highlights

Merchant is affiliated with Vanderbilt University, where he continues to engage in research and development in the field of oncology. His work at the university allows him to collaborate with other experts and contribute to advancements in cancer research.

Collaborations

Some of his notable coworkers include R Daniel Beauchamp and Bonnie J LaFleur. Their collaborative efforts aim to further explore the potential of the FJX1 protein in cancer therapies.

Conclusion

Nipun B Merchant's innovative contributions to cancer diagnosis and treatment highlight the importance of research in developing new therapeutic options. His work has the potential to significantly impact the lives of cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…